Business & Regulation

Is it time to update your resume and fine-tune your interview skills?

Sitting Down With... David Baltimore, Nobel Laureate, President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology, USA.

Learning when to abandon an R&D project can open the door to potential future gains.

CPhI Worldwide 2015 in Madrid is just around the corner. Are you ready for showtime?

Drug companies claim that off-label drug promotion is protected by freedom of speech.

Dissecting a ligand into smaller fragments can provide a strategy for analyzing the role of key functional groups in a protein-ligand interaction.

Abusers are finding ways to circumvent current abuse-deterrent measures, leaving companies in need of new strategies.

The December issue will feature our inaugural Innovation Awards, recognising the most exciting new technologies of 2015.

Sitting Down With… Carsten Brockmeyer, CEO, Formycon, Germany.

The US Centers for Disease Control and Prevention has officially declared an “epidemic of prescription drug abuse”.